J Basic Clin Physiol Pharmacol
In a study where tirzepatide was added to insulin glargine, patients with an A1C 8% reduced their insulin glargine dose by 20% when initiating tirzepatide
Although Ozempic isnt FDA-approved for weight loss, its active ingredient, semaglutide, has been shown to be quite effective
For these reasons, surgical teams now routinely screen patients for semaglutide use and implement appropriate protocols based on individual risk assessment
Biology, Mendelian randomisation, and discordance data all point in that direction, but we are not there yet with trial data
In addition to these most popular options, other medications are available, but they require daily injections, making them less convenient than semaglutide